Tvardi Therapeutics, Inc. (FRA:69C)

Tvardi Therapeutics Statistics

Total Valuation

FRA:69C has a market cap or net worth of EUR 28.98 million. The enterprise value is -1.77 million.

Market Cap	28.98M
Enterprise Value	-1.77M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	9.38M
Shares Outstanding	n/a
Shares Change (YoY)	+170.52%
Shares Change (QoQ)	+10.90%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	6.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.22
P/TBV Ratio	1.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.09
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.48, with a Debt / Equity ratio of 0.01.

Current Ratio	3.48
Quick Ratio	3.30
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -135.64% and return on invested capital (ROIC) is -105.82%.

Return on Equity (ROE)	-135.64%
Return on Assets (ROA)	-72.68%
Return on Invested Capital (ROIC)	-105.82%
Return on Capital Employed (ROCE)	-107.08%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-1.68M
Employee Count	12
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	2.93
200-Day Moving Average	14.75
Relative Strength Index (RSI)	37.97
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.54M
Pretax Income	-20.15M
Net Income	-20.15M
EBITDA	-25.46M
EBIT	-25.54M
Earnings Per Share (EPS)	-2.75

Balance Sheet

The company has 31.07 million in cash and 194,324 in debt, with a net cash position of 30.88 million.

Cash & Cash Equivalents	31.07M
Total Debt	194,324
Net Cash	30.88M
Net Cash Per Share	n/a
Equity (Book Value)	23.75M
Book Value Per Share	2.53
Working Capital	23.36M

Cash Flow

Operating Cash Flow	-19.30M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:69C does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-170.52%
Shareholder Yield	-170.52%
Earnings Yield	-69.53%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2